These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
262 related items for PubMed ID: 16733150
1. Restaging patients with N2 (stage IIIa) non-small cell lung cancer after neoadjuvant chemoradiotherapy: a prospective study. Cerfolio RJ, Bryant AS, Ojha B. J Thorac Cardiovasc Surg; 2006 Jun; 131(6):1229-35. PubMed ID: 16733150 [Abstract] [Full Text] [Related]
2. FDG-PET imaging for lymph node staging and pathologic tumor response after neoadjuvant treatment of non-small cell lung cancer. Ohtsuka T, Nomori H, Ebihara A, Watanabe K, Kaji M, Naruke T, Suemasu K, Uno K. Ann Thorac Cardiovasc Surg; 2006 Apr; 12(2):89-94. PubMed ID: 16702929 [Abstract] [Full Text] [Related]
3. The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy. Cerfolio RJ, Bryant AS, Ohja B, Bartolucci AA, Eloubeidi MA. J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1232-41. PubMed ID: 15942562 [Abstract] [Full Text] [Related]
4. The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer. Cerfolio RJ, Ojha B, Bryant AS, Raghuveer V, Mountz JM, Bartolucci AA. Ann Thorac Surg; 2004 Sep; 78(3):1017-23; discussion 1017-23. PubMed ID: 15337041 [Abstract] [Full Text] [Related]
5. Risk factors for occult mediastinal metastases in clinical stage I non-small cell lung cancer. Lee PC, Port JL, Korst RJ, Liss Y, Meherally DN, Altorki NK. Ann Thorac Surg; 2007 Jul; 84(1):177-81. PubMed ID: 17588407 [Abstract] [Full Text] [Related]
6. The treatment of patients with stage IIIA non-small cell lung cancer from N2 disease: who returns to the surgical arena and who survives. Cerfolio RJ, Maniscalco L, Bryant AS. Ann Thorac Surg; 2008 Sep; 86(3):912-20; discussion 912-20. PubMed ID: 18721582 [Abstract] [Full Text] [Related]
13. Characteristics of advantages of positron emission tomography over computed tomography for N-staging in lung cancer patients. Ebihara A, Nomori H, Watanabe K, Ohtsuka T, Naruke T, Uno K, Kuwahira I, Eguchi K. Jpn J Clin Oncol; 2006 Nov; 36(11):694-8. PubMed ID: 17068084 [Abstract] [Full Text] [Related]
14. Predictors of survival and disease-free survival in patients with resected N1 non-small cell lung cancer. Cerfolio RJ, Bryant AS. Ann Thorac Surg; 2007 Jul; 84(1):182-8; discussion 189-90. PubMed ID: 17588408 [Abstract] [Full Text] [Related]
15. Ability of positron emission tomography to detect residual neck node disease in patients with head and neck squamous cell carcinoma after definitive chemoradiotherapy. Tan A, Adelstein DJ, Rybicki LA, Saxton JP, Esclamado RM, Wood BG, Lorenz RR, Strome M, Carroll MA. Arch Otolaryngol Head Neck Surg; 2007 May; 133(5):435-40. PubMed ID: 17515501 [Abstract] [Full Text] [Related]
18. Repeat mediastinoscopy in all its indications: experience with 96 patients and 101 procedures. Call S, Rami-Porta R, Obiols C, Serra-Mitjans M, Gonzalez-Pont G, Bastús-Piulats R, Quintana S, Belda-Sanchis J. Eur J Cardiothorac Surg; 2011 Jun; 39(6):1022-7. PubMed ID: 21112217 [Abstract] [Full Text] [Related]
19. [Multimodal treatment of non small cell lung cancer]. Stoelben E, Digel W, Henke M, Passlick B. Zentralbl Chir; 2006 Apr; 131(2):110-4. PubMed ID: 16612776 [Abstract] [Full Text] [Related]
20. Baseline SUVmax at PET-CT in stage IIIA non-small-cell lung cancer patients undergoing surgery after neoadjuvant therapy: prognostic implication focused on histopathologic subtypes. Lee HY, Lee KS, Park J, Han J, Kim BT, Kwon OJ, Ahn YC, Ahn MJ, Park K, Kim J, Shim YM. Acad Radiol; 2012 Apr; 19(4):440-5. PubMed ID: 22265854 [Abstract] [Full Text] [Related] Page: [Next] [New Search]